Kennedys pharmacy compounding advisory committee, which passes along official recommendation to the broader FDA for approval, suggested that several peptides be moved out of the significant safety risk category, and into one that would allow compounding companies to legally make injectable peptides without backing, and sometimes even without an inspection
B12 deficiency isnt just a vegan problem
These numbers compare well to other treatments
Our findings broadly support the advice to discontinue GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation, and also support the ongoing registration of pregnancy outcomes in pharmacological databases since the amount of available data is scarce and mostly limited to animal studies
Yu T, Liu M, Luo H, et al
10.1210/clinem/dgaf401 J Clin Endocrinol Metab